Study: Aspirin cuts death risk in prostate cancer patients

10/25/2010 | WebMD

Preliminary results from a large study show that anti-coagulants, particularly aspirin, reduced the risk of death by more than 50% for men with prostate cancer that had not spread beyond the gland. Patients who took anti-coagulants were also less likely to experience cancer recurrence than those who didn't take such drugs.

View Full Article in:

WebMD

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Accreditation
Meridian Health Plan
Detroit, MI
Stop Loss Sales Executive, (Southern Region)
Indigo Insurance Services
Multiple Locations, SL_Multiple Locations
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC